Finnish Health Tech Firm Develops Acoustic Breathing Monitor

Alveos' new sensing method tracks respiration through chest vibrations

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Finland-based health tech company Alveos has developed a new acoustic sensing method designed to monitor human breathing by detecting subtle chest vibrations and pressure changes. The approach aims to enable continuous, noninvasive respiratory monitoring in everyday situations, addressing limitations of optical, camera-based and motion-derived techniques commonly used in consumer wearables.

Why it matters

Respiratory rate and breathing patterns are increasingly recognized as indicators of physical exertion, stress, recovery and autonomic nervous system activity. However, continuous measurement in real-world conditions has remained technically challenging. Alveos' acoustic approach seeks to provide a more robust and unobtrusive solution for tracking breathing outside of clinical settings.

The details

Alveos' sensing system uses high-sensitivity acoustic sensors placed in contact with the body to capture vibration patterns generated by airflow and chest wall motion during respiration. These signals are processed on-device to characterize breathing rate, rhythm, and depth without the use of cameras, airflow masks, or optical measurements. The sensor system features a magnetic clip that attaches to clothing, while the sensor surface maintains stable contact against the skin, eliminating the need for adhesives or skin preparation.

  • Alveos was founded in Finland and operates across the United States and Finland.
  • The company said it is planning a market launch of its product in the fourth quarter of 2026.
  • Alveos has completed pre-seed funding at a reported valuation of approximately €5 million.

The players

Alveos

A health technology company developing noninvasive methods for continuous respiratory monitoring. The company combines acoustic sensing, applied physiology, and data science to study how breathing patterns reflect physical and mental states in real-world contexts.

Patrick Obolgogiani

The chief executive officer of Alveos.

Got photos? Submit your photos here. ›

What they’re saying

“Our work builds on decades of research in respiratory physiology and acoustics. The challenge has been translating that science into a sensing modality that can operate continuously outside the clinic. By focusing on chest vibrations rather than optics or airflow, we are exploring a pathway that is both noninvasive and compatible with everyday use.”

— Patrick Obolgogiani, Chief Executive Officer, Alveos (businessinsider.com)

“Breathing is one of the few physiological functions that is both automatic and voluntarily adjustable. Our goal is to provide people with access to validated respiratory measurements that help them understand their breathing patterns, rather than relying on estimates or intermittent snapshots.”

— Patrick Obolgogiani, Chief Executive Officer, Alveos (businessinsider.com)

What’s next

Alveos said it is planning a market launch of its product in the fourth quarter of 2026, with pre-orders currently available through a Kickstarter campaign. The company is also focused on ongoing validation efforts to ensure measurement robustness across different body types, activity levels, and environmental conditions.

The takeaway

Alveos' acoustic sensing approach represents an innovative step in the development of unobtrusive, continuous respiratory monitoring technologies that can function outside of clinical settings. By focusing on chest vibrations rather than optical or airflow-based techniques, the company aims to provide a more practical solution for tracking breathing patterns in everyday life.